Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Mendelian Disorders Testing Companies

ID: MRFR/LS/4053-HCR
90 Pages
Rahul Gotadki
Last Updated: February 16, 2025
In the field of genetic testing, Mendelian Disorders Testing companies focus on providing diagnostic solutions for inherited genetic disorders. These organizations contribute to advancements in precision medicine by offering comprehensive testing services.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Mendelian Disorders Testing Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)10.01%
2024 Market Size$ 0.43 Billion
2025 Market Size$ 0.47 Billion
2035 Market Size$ 1.23 Billion
Key Players
Illumina
Thermo Fisher Scientific
Agilent Technologies
F. Hoffmann-La Roche
PerkinElmer
Myriad Genetics
Trends
  • Technological Advancements in Genetic Testing
  • Increased Awareness and Demand for Genetic Testing
  • Regulatory Developments and Standardization
Opportunities
  • Rising Prevalence of Mendelian Disorders
  • Regulatory Developments and Standardization
  • Technological Advancements in Genetic Testing
Summary Table of Contents Segmentation Methodology Download PDF

Top Industry Leaders in the Mendelian Disorders Testing Market

Mendelian Disorders Testing Market
 

Latest Mendelian Disorders Testing Companies Updates:

Illumina: Launched the TruSight One Expanded Carrier Screening panel, covering over 500 conditions, including numerous Mendelian disorders.

Invitae: Secured FDA approval for its Myriad Foresight carrier screening test, expanding their offerings in prenatal and preconception testing.

Sophia Genetics: Partnered with Illumina to develop and commercialize AI-powered solutions for analyzing whole-genome sequencing data in Mendelian disorders.

Fulgent Genetics: Announced the launch of its Gene Finder test, enabling comprehensive analysis of rare genetic variants for personalized diagnosis and treatment.

List of Mendelian Disorders Testing Key companies in the market:

  • Celera Group (U.S.)
  • Abbott Laboratories (U.S.)
  • ELITechGroup (France)
  • Quest Diagnostics (U.S.)
  • AutoGenomics (U.S.)
  • PerkinElmer Inc. (U.S.)
  • Roche Diagnostics (Switzerland)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Applied Biosystems Inc. (U.S.)

Related Reports

No regional reports available for this market.

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035